Healthcare -
Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - STOCK-BASED COMPENSATION
Stock-based Compensation ELVN - Enliven Therapeutics, Inc.
12.9 M
LAST VALUE
159.08%
2 YEAR CAGR
87.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR